RELIEF THERAPEUTICS HLDG AG NAMEN -AKT
COM · CUSIP H6759S100
2
institutional holders
-2 vs Q3 2021
450.0k
shares reported held*
$30.0kreported value*
0 new
0 added
0 reduced
1 sold out
net sold ≈ $1.8k (-45.8k shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $0.07.
Trends to Q4 2021
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2020 | 2 |
| Q4 2020 | 4 |
| Q1 2021 | 4 |
| Q2 2021 | 6 |
| Q3 2021 | 4 |
| Q4 2021 | 2 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2020 | 4 | 1 |
| Q1 2021 | 2 | 0 |
| Q2 2021 | 3 | 0 |
| Q3 2021 | 2 | 2 |
| Q4 2021 | 0 | 1 |
Biggest buyers
| None |
Biggest sellers
| Stonebridge Financial Planning Group, LLC | Sold out | -45.8k |
Holders, Q4 2021
| Manager | Shares | Change |
|---|---|---|
| HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 0.01% of their portfolio | 300.0k $20.0k | Unchanged |
| Ancora Advisors LLC 0.00% of their portfolio | 150.0k $10.0k | Unchanged |